- Home
- BKU vs BSX Comparison
BKU vs BSX Comparison
Compare BKU & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKU
- BSX
- Stock Information
- Founded
- BKU 2009
- BSX 1979
- Country
- BKU United States
- BSX United States
- Employees
- BKU N/A
- BSX N/A
- Industry
- BKU Savings Institutions
- BSX Medical/Dental Instruments
- Sector
- BKU Finance
- BSX Health Care
- Exchange
- BKU Nasdaq
- BSX Nasdaq
- Market Cap
- BKU N/A
- BSX 138.4B
- IPO Year
- BKU 2011
- BSX 1992
- Fundamental
- Price
- BKU $33.79
- BSX $103.05
- Analyst Decision
- BKU Hold
- BSX Strong Buy
- Analyst Count
- BKU 11
- BSX 23
- Target Price
- BKU $40.45
- BSX $110.57
- AVG Volume (30 Days)
- BKU 917.3K
- BSX 7.4M
- Earning Date
- BKU 04-28-2025
- BSX 04-23-2025
- Dividend Yield
- BKU 3.57%
- BSX N/A
- EPS Growth
- BKU 38.76
- BSX 15.23
- EPS
- BKU 3.21
- BSX 1.37
- Revenue
- BKU $972,198,000.00
- BSX $17,554,000,000.00
- Revenue This Year
- BKU $15.93
- BSX $15.77
- Revenue Next Year
- BKU $6.75
- BSX $10.33
- P/E Ratio
- BKU $10.80
- BSX $75.37
- Revenue Growth
- BKU 11.13
- BSX 19.36
- 52 Week Low
- BKU $26.78
- BSX $71.88
- 52 Week High
- BKU $44.45
- BSX $107.17
- Technical
- Relative Strength Index (RSI)
- BKU 57.88
- BSX 58.80
- Support Level
- BKU $32.97
- BSX $103.10
- Resistance Level
- BKU $34.80
- BSX $105.74
- Average True Range (ATR)
- BKU 1.03
- BSX 1.83
- MACD
- BKU 0.31
- BSX 0.46
- Stochastic Oscillator
- BKU 88.49
- BSX 80.83
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.